drugset / Trial / NCT03637062

Verify the Safety and Effectiveness of the Cerclage Pessary in Prevention and Treatment of High-risk Preterm Pregnancy

NCT03637062

Not yet recruiting 300 enrolled QH Medical Technology Ltd.
RandomizedParallel-groupOpen-labelTreatment

Summary

Verify the safety and effectiveness of the cerclage pessary in the prevention and treatment of high-risk preterm pregnancy.

Timeline

Start
2024-12-01
Primary completion
2026-12-01
Completion
2026-12-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Progesterone Other / unclassified 200 mg

Indications

No indication recorded.